Live News Categoriesmarket

BAYGN.DE (BAYGN.DE) News

Track canonical SquawkNews coverage tagged to BAYGN.DE, BAYGN.DE. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol BAYGN.DE Asset market Sector Markets 90 days 1 Updated Sep 28, 2026, 12:00 PM UTC Open live news feed

M Bayer says FDA accepts Lynkuet sNDA, grants priority review The U.S. FDA accepted Bayer’s supplemental New Drug Application for Lynkuet and granted Priority Review for a new indication in women receiving endocrine therapy for breast cancer. The filing is based on Phase III OASIS- EQUITY | Sep 28, 2026, 12:00 PM UTC